cancer treatment
-
Franchise India Bureau Jan 10 2019 - 1 min readEli Lilly and Co will acquire Loxo Oncology Inc for about $8 billion in cash, making its biggest bet on a cancer therapy market expected to be worth several billions of dollars. The cash deal comes on the heels of Bristol-Myers Squibb Co's agreement last week to buy Celgene Corp for $74 billion, and gives ...
-
Franchise India Bureau Nov 12 2018 - 1 min readResearchers at Indian Institute of Technology (IIT) Roorkee have created fluorescent carbon nanodots that can serve as “theranostic” (therapeutic and diagnostic) agents for cancer. Led by P Gopinath, a team of IIT Roorkee researchers has extracted these nanosized carbon materials from the leaves of the rosy periwinkle plant. P Gopinath said, "Such events of real-time ...
-
Franchise India Bureau Aug 06 2018 - 1 min readRegeneron Pharmaceuticals Inc has announced to invest $100 million in cancer drug developer bluebird bio Inc, and jointly the companies will develop new cell therapies for cancer. The investment will be at $238.10 per share, a premium of nearly 59 percent over bluebird's Friday closing price. Bluebird bio's shares were up about 7 pct at ...
-
Franchise India Bureau Jul 31 2018 - 2 min readDaiichi Sankyo Company, Limited and Glycotope GmbH have signed a global licensing agreement to develop an antibody drug conjugate (ADC) by combining Daiichi Sankyo's proprietary ADC technology with Glycotope's investigational tumor-associated TA-MUC1 antibody gatipotuzumab (formerly PankoMab-GEX), building on a previous 2017 option agreement. Daiichi Sankyo has got global exclusive rights to develop and ...
-
Franchise India Bureau Jun 01 2018 - 2 min readCancer care provider Cytecare Hospitals Pvt. Ltd has announced to have raised $31 million (around Rs 210 crore) in a Series A round of funding led by global investment bank Goldman Sachs. A group of domestic and international individuals also participated in this funding round along with Goldman, said Ferzaan Engineer, ...